Hyperliquid Strategies Inc（PURR）股票分析

$9.800

+0.341 (+3.48%)收盤時

Loading chart…

最高: 9.845
開盤: 9.000
成交量加權均價: 9.53
成交量: 13.25M
市值: —
最低: 8.954
成交金額: 126.27M
企業價值/稅息折舊攤銷前利潤（TTM）: 0.39

Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

AI 分析 of Hyperliquid Strategies Inc (PURR)

買進

Hyperliquid Strategies Inc (PURR) is a good buy right now due to its significant growth potential and strong market position. The current price is $11.11, and analysts have set a price target of $18, which represents a potential upside of 63%. Additionally, the company has shown impressive revenue growth, with Q4 2026 revenue reaching $6.33 million, and a gross margin of 100% in the last three quarters, indicating strong profitability. However, the main risk is the ongoing investigation into insider trading, which could impact market sentiment and investor confidence.